Freezing temperatures in Florida this winter have forced Tropicana to shrink orange juice carton sizes on some products and raise prices on others, according to parent company Pepsi. Continue reading Tropicana Packages Shrink as Temperatures Rise Tropicana Packages Shrink as Temperatures Rise originally appeared on DailyFinance on Fri, 12 Mar 2010 09:30:00. Filed Under: Company News , Pepsico Permalink | Tweet this! | Comments

View post:
Tropicana Packages Shrink as Temperatures Rise

We’re not even halfway through March, and it seems the month has already been marked with an abundance of failed drug studies. The most recent: Three potential cancer drugs — two from Pfizer and one from Roche — didn’t pan out in late stage clinical trials. Continue reading Cancer Drugs from Pfizer and Roche Fail in Clinical Trials Cancer Drugs from Pfizer and Roche Fail in Clinical Trials originally appeared on DailyFinance on Fri, 12 Mar 2010 09:41:00. Filed Under: Company News , Healthcare , Pfizer , Astrazeneca Permalink | Tweet this! | Comments

Read more here: 
Cancer Drugs from Pfizer and Roche Fail in Clinical Trials

Last week, Citigroup CEO Vikram Pandit said the bank owed U.S. taxpayers a “large debt of gratitude.” Reports out Wednesday show how he plans to bolster Citi’s balance sheet after repaying the government for its financial aid. Continue reading Grateful Citigroup Reveals Plans for Digging Itself Out of the Hole Grateful Citigroup Reveals Plans for Digging Itself Out of the Hole originally appeared on DailyFinance on Wed, 10 Mar 2010 12:15:00. Filed Under: Company News , Economy , Citigroup Permalink | Tweet this! | Comments

More here: 
Grateful Citigroup Reveals Plans for Digging Itself Out of the Hole

The Food and Drug Administration’s approval of using the wrinkle-smoothing drug Botox to treat elbow, wrist, and finger spasms may lead its developer, Allergan, to test it for other medical treatments, including migraines. Continue reading FDA Approves Botox for Elbow Spasms. Are Migraines Next? FDA Approves Botox for Elbow Spasms. Are Migraines Next? originally appeared on DailyFinance on Wed, 10 Mar 2010 14:03:00. Filed Under: Company News , Healthcare Permalink | Tweet this! | Comments

Here is the original: 
FDA Approves Botox for Elbow Spasms. Are Migraines Next?

Earlier this week, AstraZeneca’s widely used cholesterol-lowering drug Crestor was approved by the U.S. Food and Drug Administration for use in people with normal cholesterol to prevent heart attacks and strokes. The approval could lead to a much bigger market for Crestor, but has also led to a number of critics questioning the decision. Continue reading Wider Approval for Crestor Brings Out Cynics Wider Approval for Crestor Brings Out Cynics originally appeared on DailyFinance on Wed, 10 Feb 2010 14:50:00. Filed Under: Company News , Healthcare , Astrazeneca Permalink | Tweet this! | Comments

Excerpt from: 
Wider Approval for Crestor Brings Out Cynics

The Food and Drug Administration says it has nearly doubled the number of warnings to drugmakers for questionable promotion since President Obama took office. The agency sent 41 enforcement letters 2009, up from 21 in 2008, said Thomas Abrams, head of the FDA’s Division of Drug Marketing, Advertising, and Communication , in Reuters . In January , the FDA sent nine letters. Continue reading For Big Pharma, is Breaking the Law the Price of Doing Business? For Big Pharma, is Breaking the Law the Price of Doing Business? originally appeared on DailyFinance on Mon, 01 Feb 2010 16:09:00. Filed Under: Company News , Healthcare , Johnson & Johnson , Pfizer , Novartis , Amgen , Eli Lilly , Astrazeneca Permalink | Tweet this! | Comments

Read more here:
For Big Pharma, is Breaking the Law the Price of Doing Business?

“We must make this the decade of vaccines,” declared business tycoon turned philanthropist Bill Gates today at the World Economic Forum in Davos, Switzerland. “Vaccines already save and improve millions of lives in developing countries. Innovation will make it possible to save more children than ever before.” To put some force behind those statements, Gates, founder of software empire Microsoft ( MSFT ), and his wife Melinda also announced that their Gate Foundation will commit $10 billion over the next 10 years to help research, develop and deliver vaccines for the world’s poorest countries. The new funding is in addition to the $4.5 billion that the foundation has already committed to vaccines to date. Continue reading The Gates Foundation Makes a Bold, $10 Billion Pledge for Vaccines The Gates Foundation Makes a Bold, $10 Billion Pledge for Vaccines originally appeared on DailyFinance on Fri, 29 Jan 2010 13:00:00. Filed Under: Healthcare , Pfizer , Sanofi Aventis , Merck , GlaxoSmithKline , Novartis Permalink | Tweet this! | Comments

Read more:
The Gates Foundation Makes a Bold, $10 Billion Pledge for Vaccines

In a move that came as a surprise to no one, AT&T Inc. ( T ) quietly ended its sponsorship of Tiger Woods — making it one of the biggest companies to drop the embattled golf pro. The telecom company, whose logo appears on Woods’ golf bag, did not give a reason for its decision. However, does the company really even need to provide one? Continue reading AT&T Is the Latest Sponsor to Say Goodbye to Tiger Woods AT&T Is the Latest Sponsor to Say Goodbye to Tiger Woods originally appeared on DailyFinance on Thu, 31 Dec 2009 12:30:00. Filed Under: People , Media , Pfizer , AT&T Permalink | Tweet this! | Comments

Read the rest here:
AT&T Is the Latest Sponsor to Say Goodbye to Tiger Woods

GMAC Financial Services is expected to receive $3.5 billion more in federal aid to further stabilize the automotive lender, The Wall Street Journal reported Tuesday. The announcement is expected within days and would coincide with GMAC taking more steps to absorb losses related to its mortgage operations, the newspaper reported, citing people familiar with the situation. Continue reading Struggling GMAC Reportedly Set for New Round of U.S. Aid Struggling GMAC Reportedly Set for New Round of U.S. Aid originally appeared on DailyFinance on Wed, 30 Dec 2009 07:12:00. Permalink | Tweet this! | Comments

Read the rest here: 
Struggling GMAC Reportedly Set for New Round of U.S. Aid

The following is a round-up of news likely to affect stock prices today : Nokia ( NOK ) filed a complaint against Apple ( AAPL ) with the U.S. International Trade Commission over patent infringements in “virtually all” of its mobile devices, portable music players, and computers. Continue reading Stocks in the News: Pfizer, Nokia, Apple Stocks in the News: Pfizer, Nokia, Apple originally appeared on DailyFinance on Wed, 30 Dec 2009 08:03:00. Filed Under: Company News , Investing Permalink | Tweet this! | Comments

Read the rest here: 
Stocks in the News: Pfizer, Nokia, Apple